Key facts
- Notable investors include Optics Valley Industry Investment, Dongke Chuangxing.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Xindong Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Xindong Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Xindong Biotechnology
Distributor of pet food and supplies intended for veterinary pharmaceutical research purposes. The company provides experimental animals, disease model development, preclinical pharmacological evaluation, and technical consulting services, enabling the global pet medicine market to access integrated research capabilities, standardized testing environments, and comprehensive support for advancing drug discovery, clinical validation, and translational applications across companion animal health domains.
- Sector
- Business Products and Services (B2B)
- HQ
- Wuhan, China
- Founded
- 2023
- Ownership
- Privately Held (backing)
Xindong Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Xindong Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Xindong Biotechnology in its N-PORT filings yet. We sweep new filings monthly.